Cargando…

Correction: Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer's Disease

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374678/ https://www.ncbi.nlm.nih.gov/pubmed/25812032 http://dx.doi.org/10.1371/journal.pone.0121509

Ejemplares similares

Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
por: Wes, Paul D., et al.
Publicado: (2014)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Correction: Curcumin and Apigenin – novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease
Publicado: (2015)

Correction: Tau-Mediated Nuclear Depletion and Cytoplasmic Accumulation of SFPQ in Alzheimer's and Pick's Disease
por: Ke, Yazi, et al.
Publicado: (2012)

Author Correction: Comparative profiling of cortical gene expression in Alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation
por: Castillo, Erika, et al.
Publicado: (2021)

Correction: Learning Gene Networks under SNP Perturbations Using eQTL Datasets
Publicado: (2014)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Correction: Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy
por: Brody, A. Harrison, et al.
Publicado: (2022)

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
por: Chen, Yijun, et al.
Publicado: (2023)

Correction to: Understanding the impact of antibiotic perturbation on the human microbiome
por: Schwartz, Drew J., et al.
Publicado: (2021)

Correction to: Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021)

Correction to: Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
Publicado: (2023)

Correction to: Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
por: Shi, Yang, et al.
Publicado: (2021)

Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2022)

Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
por: Vogel, Jacob W., et al.
Publicado: (2021)

Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer’s Disease
por: Canchi, Saranya, et al.
Publicado: (2019)

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Sun, Xiao-ying, et al.
Publicado: (2021)

Correction: Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217
por: Groot, Colin, et al.
Publicado: (2022)

Correction: Expression Analysis of All Protease Genes Reveals Cathepsin K to Be Overexpressed in Glioblastoma
por: Verbovšek, Urška, et al.
Publicado: (2015)

Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Correction: A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease
por: Modi, Khushbu K., et al.
Publicado: (2017)

Correction: AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
por: Ising, Christina, et al.
Publicado: (2017)

Correction: Genes Confer Similar Robustness to Environmental, Stochastic, and Genetic Perturbations in Yeast
por: Lehner, Ben
Publicado: (2010)

Correction: P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation
por: Kooij, Gijs, et al.
Publicado: (2010)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Vascular smooth muscle cell dysfunction contribute to neuroinflammation and Tau hyperphosphorylation in Alzheimer disease
por: Aguilar-Pineda, Jorge A., et al.
Publicado: (2021)

Correction to: Pathway crosstalk perturbation network modeling for identification of connectivity changes induced by diabetic neuropathy and pioglitazone
por: de Anda-Jáuregui, Guillermo, et al.
Publicado: (2019)

Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation
por: Errea, Oihana, et al.
Publicado: (2017)

Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease
por: Burns, Lindsay H., et al.
Publicado: (2017)

Correction: Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser(262) and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons
Publicado: (2014)

Correction: Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Correction to: Complement in the pathogenesis of Alzheimer’s disease
por: Paul Morgan, B.
Publicado: (2018)

Correction: Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer’s disease mouse model
por: Rocchio, Francesca, et al.
Publicado: (2020)

Correction: Relationship between Adiponectin Gene Polymorphisms and Late-Onset Alzheimer's Disease
Publicado: (2015)

Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
por: Verma, Ankit, et al.
Publicado: (2023)

Neuroinflammation in Alzheimer’s disease
por: Zhang, Fengjin, et al.
Publicado: (2015)

Neuroinflammation in Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

Correction: Correction: Engineered Promoters for Potent Transient Overexpression
Publicado: (2016)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qh2rrdvagmolcmm9gd8285434i